Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

At the Intersection: Searching for Clients with Bottomless Wallets

Pamela Woldow

... My clients are not fee-sensitive." Is this statement reality or wishful thinking?

Features

Alternative Fee Agreements

Kris Satkunas

There have been a spate of reports the last few months on alternative fee agreements that have stirred a tremendous amount of conversation in the industry. Some of the conversation is helpful, some of it is constructively critical, and some of it is quite simply confusing.

New ISO Forms Impact Construction Contracts

Heather N. Sharp & Seth A. Schmeeckle

ISO started introducing new commercial general liability forms and endorsements in April 2013. In this new rollout, ISO makes 11 coverage form changes, including a change to the Other Insurance provision, and over 80 endorsement changes.

Features

Insurance Coverage for Gun Injuries

Chet A. Kronenberg & Colin Rolfs

The insurance industry is no stranger to gun-related claims. Although myriad scenarios give rise to such claims, three coverage issues tend to predominate in these cases.

Features

The NLRB's New Focus

ALM Staff & Law Journal Newsletters

Employee handbooks are getting new scrutiny from the NLRB. Here's what you need to know.

Features

Section 3 of DOMA Ruled Unconstitutional

Ren'e W. O’Rourke

For those employees for whom the employee's state of residence recognizes the same-sex marriage, the benefit plans must recognize the employee's same-sex marriage in the same manner as an opposite-sex marriage.

Clearer Employer Liability Standards for Title VII Supervisor Harassment and Retaliation Claims

Alexis M. Dominguez

This summer, the Supreme Court issued a pair of important employer-friendly decisions. This article offers an in-depth analysis of both decisions and what they mean to your practice.

Columns & Departments

Business Crimes Hotline

ALM Staff & Law Journal Newsletters

Analysis of two key cases.

Columns & Departments

In the Courts

ALM Staff & Law Journal Newsletters

A look at a case involving wiretap evidence.

Features

Strauss/Steffen, District Court Personal Jurisdiction and U.S.-Nexus Rulings

Andrew M. Levine, Bruce E. Yannett, Steven S. Michaels & Scott N. Auby

On Feb. 8 and 19, 2013, two judges of the United States District Court for the Southern District of New York ruled on whether foreign nationals residing continuously outside the United States may be prosecuted on civil FCPA charges by the SEC.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›